

































This masterclass is designed to explore partnerships relating to AI in drug discovery, including the importance of innovation, strategy, and steps to commercialization.
Join this meeting to discuss numerous topics on navigating this market, including:
Accelerated Lead Identification: can AI drastically reduce the time required for lead identification in drug discovery, which is crucial for rare diseases?
Optimized Drug Design: can AI enhance drug design by intelligently tweaking molecular structures, reducing side effects, and improving efficacy?
Predictive Analysis in Clinical Trials: can AI streamline clinical trials concerning patient responses, making trials more efficient and reducing the overall time and cost to bring new drugs to market?